Tioma Therapeutics' Series A - II Round

Tioma Therapeutics raised a round of funding on August 16, 2016.

Tioma Therapeutics, formerly Vasculox, is a biopharmaceutical company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers.…

Articles about Tioma Therapeutics' Series A - II Round: